Viewing Study NCT04835961


Ignite Creation Date: 2025-12-24 @ 1:09 PM
Ignite Modification Date: 2025-12-28 @ 5:09 PM
Study NCT ID: NCT04835961
Status: COMPLETED
Last Update Posted: 2023-11-01
First Post: 2021-04-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice.
Sponsor: Elpen Pharmaceutical Co. Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module